Facebook
X
LinkedIn
Forward
Oncology 102: An In-Depth Hematology and Oncology Review for Advanced Practice Providers (On-Demand) 2027
Oncology 102: An In-Depth Hematology and Oncology Review for Advanced Practice Providers (On-Demand) 2027
To meet the cancer care needs of all patients, advanced practice providers (APPs), whose education and training focus on health promotion, disease prevention, and primary care medical management, have been increasingly sought-after to fill this shortage. However, many new APPs have little background and training in oncology. As a result, oncology practices need to provide new staff with an onboarding program to help further their knowledge of hematology and oncology.
To assist APPs in their new careers in oncology-based practices, Horizon CME, in partnership with APAO, has developed “Oncology 102: An In-Depth Hematology and Oncology Review for Advanced Practice Providers.” In this on-demand program, clinicians will gain a greater understanding of cancer treatment, cancer therapies, side effects, supportive care strategies, palliative care, and more. Expert faculty will provide a detailed review of treatment strategies for hematologic disorders and solid malignancies. Participation in the program will allow APPs to build upon the foundational knowledge acquired in Oncology 101 and provide APPs with a deeper understanding of the cancer treatment strategies they need to support and care for cancer patients as part of the multidisciplinary oncology care team.
Learning Objectives.
- Describe the presentation, evaluation, and treatment of common, solid, and hematologic malignancies
- Recognize the presentation, evaluation, and treatment of common benign hematologic disorders
- Summarize the role of genetics and molecular testing in cancer care
- Compare and contrast the various types of cancer treatment including stem cell transplant, chemotherapy, targeted therapies, radiotherapy, and immunotherapy
- Identify and appropriately manage common oncologic emergencies
- Outline the role of palliative care and effectively incorporate it into oncology practice
Target Audience
This activity is intended for oncology nurse practitioners, physician assistants, nurses, nurse navigators, medical assistants, and other healthcare providers involved in the care of cancer patients.
Presented By
Course summary
- 21.75 AMA PRA Category 1 Credit™
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.
Horizon CME designates this Enduring activity for a maximum of 21.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 21.75 ANCC
This nursing continuing professional development activity was approved by Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center’s Commission on Accreditation.Upon completion, NPs and RNs will be awarded up to 21.75 credit.
- 12.00 Pharmacology
This nursing continuing professional development activity was approved by Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center’s Commission on Accreditation.Upon completion, NPs and RNs will be awarded up to 12.00 credit.
Commercial Support: This educational activity is supported by independent medical education grants from Merck Sharp & Dohme LLC, Johnson & Johnson, and Revolution Medicines.
(01) Biomarker Testing: Understanding The How, Benefits, and Translating to Patient Care
» Anthony J. Olszanski, RPh, MD - Vice-Chair Clinical Research | Department of Hematology/Oncology | Director, Phase 1 Developmental Therapeutics Program | Director, Medical Oncology Melanoma Program | Fox Chase Cancer Center | Philadelphia, PA
(02) Patience and Understanding: Palliative Care for the APP Understanding The How, Benefits, and Translating to Patient Ca » Alicia M. Rigby, MSN, RN, APRN, AOCNP - University of California, Davis
(01 - 02) Stump the Faculty - Panel Q&A Discussion - 3:25 minutes
(03) Pain Management: An Integral Component of Caring for the Oncology Patient -
» Tanya Uritsky, PharmD, BCPP - Opioid Stewardship Coordinator PGY2 Pain Management & Palliative Care Residency Program Director Hospital of the University of Pennsylvania
(04) What is Chemotherapy? - 55:01 minutes
» Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP - University of Illinois College of Pharmacy
(03 - 04) Stump the Faculty - Panel Q&A Discussion - 2:29 minutes (0.00 Credit)
(05) Modern Management of Melanoma: Immunotherapy and Targeted Therapy in Focus - 31:12 minutes (0.50 Credit)
» Suzanne McGettigan, CRNP, ANP-BC, AOCN - Oncology Nurse Practitioner, Abramson Cancer Center Associate Director of Clinical Services, Tara Miller Melanoma Center University of Pennsylvania Health System
(06) Identification and Management of Immune Related Adverse Events - 30:24 minutes (0.50 Credit)
» Jennifer Brownell, PharmD - Ambulatory pharmacy manager Clearview Cancer Institute
(07) Deciphering Radiation Oncology: A Deeper Dive into Tumor-Specific Strategies and Technological Innovations - 49:30 minutes (1.00 Credit)
» Bridgett Harr, CNP - Nurse Practitioner Cleveland Clinic
(05 - 07) Stump the Faculty - Panel Q&A Discussion - 9:34 minutes (0.25 Credit)
(08) Neuro-Oncology for the APP: What is Going on Up There? - 37:39 minutes (0.50 Credit)
» Vanessa Nevins, PA-C, RDMS, RT - Oncology Physician Assistant Yale New Haven Smilow Cancer Hospital
(08) Stump the Faculty - Panel Q&A Discussion - 11:06 minutes (0.25 Credit)
(09) Breast Oncology: Awareness and Current Knowledge - 58:39 minutes (1 Credit)
» Kayla Freeman, DNP, APRN, FNP-C - Breast Oncology Nurse Practitioner Emory Winship Cancer Institute
(10) Gastric Cancer: A Review of Current and Emerging Treatment Modalities - 29:52 minutes (0.50 Credit)
» Sujata Kane, MS, RD, PA-C - Physician Assistant Winship Cancer Institute, Emory University
(10) Stump the Faculty - Panel Q&A Discussion - 4:54 minutes (0.25 Credit)
(11) Lung Cancer: Updates and Advancements - 52:58 minutes
» Beth Sandy, MSN, CRNP - Nurse Practitioner, Thoracic Medical Oncology Abramson Cancer Center, University of Pennsylvania
(12) Updates in Treating and Managing Patients with Prostate, Bladder and Renal Cell Carcinoma - 58:30 minutes (1 Credit)
» Michael Lai ARNPP - Nurse Practitioner Seattle Cancer Care Alliance - 28:07 minutes
» Laura S. Wood, RN, MSN, OCN - Cleveland Clinic - 30:23 minutes
(11 - 12) Stump the Faculty - Panel Q&A Discussion - 10:28 minutes (0.25 Credit)
(13) Head and Neck Cancer: Diagnosis, Staging, and Management - 63:23 minutes (1.00 Credit)
» Kristin M. Daly, MSN, ANP-BC, AOCNP - Medical Oncology Siteman Cancer Center Washington University, St. Louis School of Medicine
(14) Colorectal and Gastric Cancer: Current Treatments, and Emerging Therapies - 50:48 minutes (0.75 Credit)
» Sujata Kane, MS, RD, PA-C - Physician Assistant Winship Cancer Institute, Emory University
(13 - 14) Stump the Faculty - Panel Q&A Discussion - 13:18 minutes
(15) Multidisciplinary Management of Hepatocellular Carcinoma and Pancreatic Adenocarcinoma - 57:29 minutes (1.00 Credit)
» Katie L. Green, CRNP, MSN - NP, Medical Oncology Abramson Cancer Center - 21:05 minutes
» Taylor Aldridge, MMS, PA-C - PA, Division of Surgical Oncology, Stanford University - 36:24 minutes
(16) Gynecologic Malignancies: Clinical Pearls - 33:31 minutes (1 Credit)
» Rachel Frankenthal, PA-C, MPH, MSCP - Gynecologic Oncology Physician Associate UCLA Health
(15 - 16) Stump the Faculty - Panel Q&A Discussion - 2:47 minutes (0.00 Credit)
(17) A Deep Dive into Multiple Myeloma - 59:15 minutes (1.00 Credit)
» Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN - Nurse Practitioner Department of Hematology and Medical Oncology Cleveland Clinic
» Donna Catamero, ANP-BC, OCN, CCRC - Associate Director of Myeloma Research Icahn School of Medicine
(17) Stump the Faculty - Panel Q&A Discussion - 15:02 minutes (0.25 Credit)
(18) Advances in CLL for the Clinical Oncology APP - 33:03 minutes (0.50 Credit)
» Lisa Nodzon PhD, APRN, AOCNP - Advanced Registered Nurse Practitioner Moffitt Cancer Center
(19) Follicular Lymphoma for the Clinical Oncology APP - 26:36 minutes (0.50 Credit)
Alex Palmer » RN, MSN, FNP- Emory Winship Cancer Institute
(18 - 19) Stump the Faculty - Panel Q&A Discussion - 5:27 minutes (0.00 Credit)
(20) Understanding and Managing Acute Leukemia, Myelodysplastic Syndrome, and Myelofibrosis - 54:29 minutes (0.75 Credit)
» Jennie M. Goble, PA-C - Physician Assistant Mayo Clinic
(21) Emerging Therapies and Strategies in Classical Hematology: Bleeding and Thrombocytopenia - 85:24 minutes (1.25 Credit)
» Peter Hakos, PA-C - Physician Assistant Genesis Care - UF Health Oncology
» Lauren Imboden, PA-C - Physician Assistant Atrium Wake Forest Baptist Health
(22) Cancer and Sexuality 102: Beyond the ‘What’ - 43:00 minutes (0.75 Credit)
» Anne Katz, PhD, RN, FAAN - AASECT-Certified Sexuality Counselor CancerCare Manitoba
(23) An Update of Current Treatment Options for Patients with Diffuse Large B-Cell Lymphoma - 34:52 minutes (0.75) Credit
» Amitkumar Mehta, MD - Professor of Medicine, Director of Lymphoma - CAR-T Cell Therapy Program - University of Alabama
(22 - 23) Stump the Faculty - Panel Q&A Discussion 6:41 minutes (0.00 Credit)
Planning Committee
Beth Faiman, PHD, MSN, APN-BC, AOCN, BMTCN, FAAN
Nurse Practitioner
Department of Hematology and Medical Oncology Cleveland Clinic
Cleveland, OH
Beth Sandy, MSN, CRNP
Nurse Practitioner, Thoracic Medical Oncology
Abramson Cancer Center, University of Pennsylvania
Philadelphia, PA
Val R. Adams, PharmD, FCCP, FHOPA, BCOP
Associate Professor, Oncology Specialist
University of Kentucky
Lexington, KY
Leigh Ann Childress MSN, NP, AOCNP
Director of Advanced Practice
Clearview Cancer Institute
Huntsville, AL
Danielle Roberts PA-C
Physician assistant with the Bone Marrow Transplant team
Winship Cancer Institute of Emory University
Atlanta, GA
Faculty
Anthony J Olszanski, RPh, MD
Physician
Fox Chase Cancer Center
Philadelphia, PA
Alicia M. Rigby MSN, RN, APRN, AOCNP
Nurse Practitioner
UC Davis Cancer Center
Sacramento, CA
Tanya Uritsky PharmD, BCPP
Opioid Stewardship Coordinator
University of Pennsylvania (HUP)
Philadelphia, PA
Michael Lai,
Nurse Practitioner
Seattle Cancer Care Alliance
Seattle, WA
Kathryn Green, CRNP, MSN
Nurse Practitioner
Abramson Cancer Center, University of Pennsylvania
Philadelphia, PA
Rachel Frankenthal, PA-C
Physician Assistant
UCLA Health
Los Angeles, CA
Jennie M. Goble, PA-C
Instructor in Medicine
Mayo Clinic
Rochester, MN
Vanessa Nevins, PA-C, RDMS, RT
Oncology Physician Assistant
New Haven Smilow Cancer Hospital
New Haven, CT
Suzanne McGettigan CRNP
Oncology Nurse Practitioner and Clinical Manager of Advanced Practice Providers and Nursing
Perelman Center for Advanced Medicine, Abramson Cancer Center
Philadelphia, PA
Bridget Harr CNP
Nurse Practitioner
Cleveland Clinic
Cleveland, OH
Taylor Aldridge
Physician Assistant
Standford Healthcare
Standford, CA
Jennifer Brownell, PharmD
Ambulatory Pharmacy Manager
Clearview Cancer Institute (CCI)
Huntsville, AL
Krisin Daily, MSN, ANP-BC AOCNP
Nurse Practitioner
St. Louis School of Medicine
St. Louis, MO
Kayla Freeman, DNP, APRN, FNP-C
Nurse Practitioner
Emory Winship Cancer Institute
Atlanta, GA
Lauren Imboden
Physician Assistant
Atrium Health Wake Forest Baptist
Winston-Salem, NC
Amitkumar Mehta, MD
Physician
University of Alabama
Tuscaloosa, Alabama
Ann Katz, PhD, RN, FAAN, AASECT-Certified Sexuality Counselor
Nurse
CancerCare Manitoba
Winnipeg, Canada
Donna Catamero, ANP-BC, OCN, CCRC
Nurse Practitioner
Icahn School of Medicine at Mount Sinai Hospital
New York, NY
Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP
Clinical Oncology Pharmacist
University of Illinois College of Pharmacy
Chicago, IL
Alexandra Palmer, RN, MSN, CRNP
Nurse Practitioner
Emory University’s Winship Cancer Institute
Atlanta, GA
Laura Wood, RN, MSN, OCN
Nurse
Cleveland Clinic, Taussig Cancer Center
Cleveland, OH
Peter Hakos, PA-C
Physician Assistant
Cleveland Clinic
Cleveland, OH
Lisa Nodzon PhD, APRN, AOCNP
Nurse Practitioner
H. Lee Moffitt Cancer Center and Research Institute
Tampa, FL
Sujata Kane, MS, RD, PA-C
Nurse Practitioner
Winship Cancer Institute, Emory University
Atlanta, GA
DISCLOSURES:
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, prior to an activity, Horizon CME requires all planners, faculty, and other contributors to disclose any financial relationships with an ACCME defined ineligible company within the past 24 months and Horizon CME has resolved any conflicts prior to this educational activity.
Planners
Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN discloses Consultant role with Janssen, GSK and Sanofi during the past 24 months.
Danielle Roberts, PA-C discloses Advisory Board role with Pfizer during the past 24 months.
Leigh Ann Childress, MSN, NP, AOCNP discloses Speaker role with AstraZeneca, Daiichi Sankyo, Amgen during the past 24 months.
Beth Sandy, MSN, CRNP discloses Speakers’ Bureau and Consultant role with Merck, AstraZeneca, Amgen, Janssen, Lilly, AbbVie, Jazz, Pfizer, Catalyst, Boehringer Ingelheim in the past 24 months.
*Horizon CME has mitigated and resolved all relevant financial relationships
Faculty
Anthony J. Olszanski, RPh, MD discloses Advisory Board role with BMS, Pfizer, Replimune, IO Biotech, Anaveon, and Signatera all these relationships have ended in the past 24 months. Active relationship with relationship with GeoVax in the past 24 months.
Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP discloses Apeaker role with Astellas during the past 24 months.
Suzanne McGettigan, CRNP, ANP-BC, AOCN discloses Consultant, Speaker and Advisory Board role with Merck, BMS, Regeneron during the past 24 months.
La-Urshalar Brock, FNP, BSN, MSN discloses Speaker role with AstraZeneca, Inc. during the past 24 months.
Beth Sandy, MSN, CRNP discloses Speakers’ Bureau and Consultant role with Merck, AstraZeneca, Amgen, Janssen, Lilly, AbbVie, Jazz, Pfizer, Catalyst, Boehringer Ingelheim in the past 24 months.
Kristin M. Daly, MSN, ANP-BC, AOCNP discloses Consultant role with Amgen, Advisory Board with Cardinal Health during the past 24 months. The relationship Speaker role with Coherus has ended in the past 24 months.
Kathryn L. Green, CRNP, MSN discloses Speaker role with Astra-Zeneca, and Jazz Pharmaceuticals during the past 24 months.
Rachel Frankenthal, PA-C, MPH, MSCP discloses Advisory Board role withSecond City Science, GSK, Corcept, Verastem. All relationships have ended in the past 24 months.
Donna Catamero, ANP-BC, OCN, CCRC discloses Speaker and Consultant roles with Regeneron, BMS, Sanofi, NJ during the past months.
Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN discloses Consultant role with Janssen, GSK and Sanofi during the past 24 months.
Lisa Nodzon, PhD, APRN, AOCNP discloses Speaker role with AstraZeneca in the past 24 mont
Peter Hakos, PA-C discloses Stock role with Pfizer during the past 24 months. Speaker role with Sanofi has ended in the past months. The Speaker role with Pharmacyclics has ended in the past 24 months.
Lauren Imboden, PA-C discloses Advisory Board role with Novo Nordisk, Pfizer, Sanofi Genzyme. All relationships have ended in the past 24 months.
Amitkumar Mehta, MD discloses Consultant and Research role with Gilead, Seattle Genetics, Incyte, Morphosys/Incyte, Kyowa Kirin, BeOne, Roche-Genentech, AstraZeneca, Incyte, Takeda, Fortyseven inc/Gilead, Juno pharmaceuticals/BMS, Celgene/BMS, Innate pharmaceuticals, Seattle Genetics, BeOne, Affimed, Merck, Kite/Gilead, Roche-Genentech, ADC therapeutics during the past 24 months.
Other Contributors
All other non-faculty contributors and others involved in the planning, development and editing/review of the content disclosed no relevant financial relationships with any entity producing, marketing, re-selling or distributing health care goods or services consumed by or used on patients.
Copyright Information
Copyright© 2026 by Horizon CME. All rights reserved. No part of this accredited continuing education activity may be
reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from Horizon CME
Available Credit
- 21.75 AMA PRA Category 1 Credit™
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.
Horizon CME designates this Enduring activity for a maximum of 21.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 21.75 ANCC
This nursing continuing professional development activity was approved by Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center’s Commission on Accreditation.Upon completion, NPs and RNs will be awarded up to 21.75 credit.
- 12.00 Pharmacology
This nursing continuing professional development activity was approved by Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center’s Commission on Accreditation.Upon completion, NPs and RNs will be awarded up to 12.00 credit.
Price
Required Hardware/software
Access to the internet is required.
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above